NCT01878331

Brief Summary

Patients with an edentulous mandible restored with implants who have participated in the core study CR 04/07 will be recruited for this extension study. No further interventions will be made for this extension study other than a clinical follow-up examination and questionnaires. Patients will not receive an investigational treatment in this study. Patients will be followed at 5 to 10 years from the date of the original implant loading

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
49

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2013

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 29, 2013

Completed
1 month until next milestone

Study Start

First participant enrolled

June 1, 2013

Completed
13 days until next milestone

First Posted

Study publicly available on registry

June 14, 2013

Completed
5.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2018

Completed
Last Updated

January 7, 2020

Status Verified

January 1, 2020

Enrollment Period

5.3 years

First QC Date

April 29, 2013

Last Update Submit

January 6, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Implant Survival

    This is a long term follow up extension study including evaluations at 5 and 10 years after the implant procedure from the core study. Implant survival will be assessed based on surviving implants for all patients at 10 years.

    10 years following implant procedure date

Secondary Outcomes (1)

  • Crestal bone level change

    5 and 10 years

Study Arms (2)

Roxolid

Patient do not receive an intervention in the extension study. Rather they are followed on the implant treatment from the core study which included a split-mouth design where all patients received both a Roxolid and SLActive implant.

SLActive

Patient do not receive an intervention in the extension study. Rather they are followed on the implant treatment from the core study which included a split-mouth design where all patients received both a Roxolid and SLActive implant.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Male or female patient ≥ 18 years of age who were provided with an implant supported over-denture in the mandible in the course of the core study (CR 04/07).

You may qualify if:

  • Subjects must have voluntarily signed the informed consent form
  • Patients must be committed to participate in the study until the ten year follow-up examinations
  • Subjects must have received treatment in the CR 04/07 core study
  • Subjects must have completed 3 year visit of core study

You may not qualify if:

  • Physical handicaps that would interfere with the ability to perform adequate oral hygiene or attend follow up visits
  • Use of any investigational drug or device during the study
  • Conditions or circumstances, in the opinion of the investigator, which would prevent completion of study participation or interfere with analysis of study results, such as history of non-compliance, unreliability

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Frauke Müller

Geneva, 1211, Switzerland

Location

Related Publications (2)

  • Muller F, Al-Nawas B, Storelli S, Quirynen M, Hicklin S, Castro-Laza J, Bassetti M, Srinivasan M; Roxolid Study Group. Small-diameter titanium grade IV and titanium-zirconium implants in edentulous mandibles: Ten-year results from a double-blind, randomised controlled split-mouth core-trial. Clin Oral Implants Res. 2024 Jan;35(1):77-88. doi: 10.1111/clr.14199. Epub 2023 Nov 9.

  • Muller F, Al-Nawas B, Storelli S, Quirynen M, Hicklin S, Castro-Laza J, Bassetti R, Schimmel M; Roxolid Study Group. Small-diameter titanium grade IV and titanium-zirconium implants in edentulous mandibles: five-year results from a double-blind, randomized controlled trial. BMC Oral Health. 2015 Oct 12;15(1):123. doi: 10.1186/s12903-015-0107-6.

MeSH Terms

Conditions

Jaw, Edentulous

Condition Hierarchy (Ancestors)

Jaw DiseasesMusculoskeletal DiseasesStomatognathic DiseasesMouth, EdentulousMouth DiseasesTooth Diseases

Study Officials

  • Frauke Müller, Prof.

    University of Geneva

    STUDY CHAIR
  • Bilal Al-Nawas, Prof.

    Klinikum der Johannes - Gutenberg - Universität Mainz

    PRINCIPAL INVESTIGATOR
  • Eugenio Romeo, Prof.

    Università degli Studi di Milano, Dipartimento di Medicina, Chirurgia e Odontoiatria

    PRINCIPAL INVESTIGATOR
  • Joke Duyck, Prof.

    Department of Oral Health Sciences, Catholic University (KU) Leuven

    PRINCIPAL INVESTIGATOR
  • Torsten E Reichert, Prof.

    Klinikum der Universität Regensburg

    PRINCIPAL INVESTIGATOR
  • Alessandro Perucchi, Prof.

    Luzerner Kantonsspital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 29, 2013

First Posted

June 14, 2013

Study Start

June 1, 2013

Primary Completion

September 1, 2018

Study Completion

September 1, 2018

Last Updated

January 7, 2020

Record last verified: 2020-01

Data Sharing

IPD Sharing
Will not share

Locations